LB-7. Weight Change in Suppressed People with HIV (PWH) Switched from Either Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) to Tenofovir Alafenamide (TAF)

BACKGROUND: Weight gain in PWH occurred in both naïve and switch studies and is linked to use of integrase inhibitors (INSTIs) with varying associations with nucleoside reverse transcriptase inhibitors (NRTIs). One hypothesis is that gain associated with TAF when switching from TDF is a result of ce...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Open Forum Infect Dis
Auteurs principaux: Sax, Paul, Althoff, Keri N, Brown, Todd T, Radtchenko, Janna, Diaz Cuervo, Helena, Ramgopal, Moti, Santiago, Steven, Moyle, Graeme, Mounzer, Karam, Elion, Richard
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2020
Sujets:
Late Breaker Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7776391/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa515.1904
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires